Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T helper type 1 cell / T helper type 2 cell balance (Th1/Th2 balance)
- Target
- Th1/Th2 balance
- Molecular classification
- Other (represents a "cellular functional balance", not a distinct molecular family; underlying signaling involves cytokines, transcription factors, but the "balance" itself is not a molecule)
01
Overview
The "T helper type 1 cell / T helper type 2 cell balance" refers to the relative functional activity between two major subtypes of CD4+ T helper lymphocytes: Th1 and Th2 cells. Th1 cells drive cellular immune responses against intracellular pathogens via secretion of IFNγ and related cytokines, while Th2 cells promote humoral (antibody-mediated) responses and protection against extracellular pathogens by releasing cytokines such as IL-4, IL-5, and IL-13. This balance is orchestrated by external cytokine milieu, master transcription factors (T-bet for Th1, GATA3 for Th2), and antigen exposure. Imbalance can lead to disease: Th1 dominance is linked to autoimmunity and chronic inflammation, while Th2 dominance is associated with allergic diseases and IgE-mediated conditions. Therapies seek to shift this balance in diseases of Th1 or Th2 dominance but must be used carefully due to the risk of tipping immune responses towards immunodeficiency or hypersensitivity.
- Other names
- Th1/Th2 balanceT helper cell balanceTh1/Th2 paradigmT helper type 1/type 2 polarization
02
Mechanism of action
Immunomodulation by: - Enhancing Th1 (e.g., IFNγ, IL-12) - Enhancing Th2 (e.g., IL-4, IL-13) - Inhibiting one axis to allow dominance of the other
03
Biological functions
Immune response regulationInflammatory responseAllergic responseAutoimmunity modulation
04
Disease associations
InflammationAutoimmune diseaseInfectionAllergyCancer (in some cases)Other immune-mediated diseases
05
Safety considerations
Increase infection risk (if Th1 suppressed)Promote allergy or asthma (if Th2 dominant)Trigger or worsen autoimmunity (if Th1 dominant)
06
Interacting drugs
No drugs interact directly with "balance;" however, drugs and biologics can skew or modulate Th1/Th2 responses. Examples include:
4 more in the full profile.
07
Biomarkers
Cytokines: IFNγ (Th1), IL-4, IL-5, IL-13 (Th2)Transcription factors: T-bet (Th1), GATA3 (Th2)Serum IgE (for Th2 bias/allergy)
Beyond the preview
Go deeper on T helper type 1 cell / T helper type 2 cell balance (Th1/Th2 balance).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on T helper type 1 cell / T helper type 2 cell balance (Th1/Th2 balance).